TL;DR
This paper provides a comprehensive scientometric analysis of the research landscape concerning rare earth elements (REEs) in cancer diagnosis and therapy. It reveals a significant surge in publications since 1980, with the US leading in output, and identifies key research areas like MRI contrast agents and cerium oxide nanoparticles as emerging frontiers.
What Problem Does This Paper Address?
Cancer remains a major global health challenge, and while various therapeutic modalities exist, the role of metals, particularly rare earth elements (lanthanides), in cancer diagnosis and treatment is an area of growing interest. Despite an increasing number of studies exploring lanthanides in this domain, there was a lack of a systematic overview analyzing the current research status, trends, and collaborative networks. This paper aims to fill that gap by mapping the scientific output and identifying key players and emerging themes in REE-based cancer research.
Methods
The authors employed a scientometric analysis approach, leveraging data from the Web of Science Core Collection. They systematically searched for publications related to "rare earth element" or specific lanthanides and "cancer" or related terms. The collected data, spanning from the inception of the database to November 2021, was then analyzed using VOSviewer software (version 1.6.16) and Microsoft Excel 2019. This analysis focused on publication years, journals, countries, institutions, authors, keywords, and co-cited references to map the research landscape, identify collaboration patterns, and forecast future trends.
Datasets
The primary dataset for this study was derived from the Web of Science Core Collection, specifically the Science Citation Index-Expanded. A total of 7,849 publications were identified and analyzed. No new datasets were introduced by the authors.
Key Insights and Ideas
- Explosive Growth: The field has seen a dramatic increase in research output, particularly after 1980, indicating a growing recognition of REEs' potential in oncology.
- Global Collaboration: While the US dominates in publication numbers, there's evidence of significant international collaboration, suggesting a global effort to harness REEs for cancer.
- Emerging Frontiers: Cerium oxide nanoparticles and photodynamic therapy have emerged as key research frontiers, especially since 2016, highlighting a shift towards novel nanomaterial-based approaches.
- Dominance of Specific REEs: Gadolinium, Lanthanum, and Yttrium are the most frequently studied REEs in this context, likely due to their established roles in imaging and therapeutic applications.
- Concentration of Expertise: Despite a large number of authors, a small fraction are highly productive, and there's a notable concentration of top institutions and journals, suggesting a specialized research community.
Key Results
- Publication Volume: A total of 7,849 publications were identified, with the first study dating back to 1945. However, significant growth only occurred after 1980, with over 77.96% of articles published between 2000 and 2021.
- Geographic Distribution: The United States was the most productive country (34.73%), followed by China (16.10%) and Germany (6.48%).
- Institutional Contributions: The Chinese Academy of Sciences led in institutional contributions (2.69%), followed by Northwestern University (1.63%) and Stanford University (1.13%).
- Journal Landscape: Radiology was the most productive journal (2.33%) and the most cited journal (5,863 citations).
- Author Productivity: Out of 33,987 authors, only 0.45% published more than 10 papers, and a substantial 79.07% published only one.
- Key Research Topics: Major themes include MRI contrast agents, photodynamic therapy, anticancer drug delivery, Yttrium-90 radioimmunotherapy for HCC, and cerium oxide nanoparticles.
Limitations and Future Work
The authors acknowledge several limitations:
- Data Source Bias: Relying solely on the Web of Science Core Collection might lead to an incomplete representation of the field, potentially missing studies from other databases.
- Language Bias: The predominance of English-language publications could introduce a bias, potentially overlooking research published in other languages.
- Keyword and Author Standardization: While efforts were made to standardize terms, the sheer volume of keywords and authors might still lead to some omissions or inconsistencies.
Future work could involve expanding the search to include other databases, analyzing a wider range of languages, and further investigating the specific mechanisms and clinical translation of promising REE-based cancer therapies. The authors also suggest that developing countries should enhance cooperation with developed nations to advance research in this area.
Summary updated